News for Tandem Diabetes Care, Inc. (0M0F.L)

Shares of Tandem Diabetes Care Inc (TNDM) fell 3.17% in mid-day trading on Apr 14. The stock reached an intraday low of $16.30, before recovering slightly to

Tandem Diabetes Care Inc (TNDM), a prominent player in the insulin delivery and diabetes technology sector, has announced that it will release its first quarter

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after th

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, announced the U.S. commercial launch of its latest Control-IQ+ technology

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, has announced the publication of positive results from its pivotal trial

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal o

[url="]Tandem Diabetes Care, Inc.[/url] (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercia

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Shares of Tandem Diabetes Care Inc (TNDM) fell 2.44% in mid-day trading on Mar 3. The stock reached an intraday low of $20.84, before recovering slightly to $

Strengths: Innovative product lineup and strong market presence in insulin pump technology.Weaknesses: Heavy reliance on insulin pump sales and the challenges

Annual Worldwide Sales: $910 million, an 18% increase year over year.Fourth Quarter Sales: $252 million, over 20% growth compared to the prior year.US Fourth Q

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsSusan Morrison - Executive Vice...

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -76% and 1.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, announced its financial results for the fourth quarter and full year endi

Quarterly Revenue: Achieved record GAAP sales of $282.6 million, surpassing the estimated $251.98 million, marking a 44% increase year-over-year.Quarterly Earn

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, has announced that its next-generation automated insulin delivery (AID) a

[url="]Tandem Diabetes Care, Inc.[/url] (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation au

Shares of Tandem Diabetes Care Inc (TNDM) surged 5.35% in mid-day trading on Feb 25. The stock reached an intraday high of $33.20, before settling at $32.64,

PR NewswireBOSTON, Feb. 14, 2025 BOSTON, Feb. 14, 2025 /PRNewswire/ -- Below is the January 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc.